Castle Biosciences, Inc. (CSTL)

USD 19.35

(0.21%)

Total Liabilities Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual total liabilities in 2023 was 86.54 Million USD , up 79.63% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly total liabilities in 2024 Q1 was 56.04 Million USD , down -35.24% from previous quarter.
  • Castle Biosciences, Inc. reported annual total liabilities of 48.17 Million USD in 2022, down -5.22% from previous year.
  • Castle Biosciences, Inc. reported annual total liabilities of 50.83 Million USD in 2021, up 115.05% from previous year.
  • Castle Biosciences, Inc. reported quarterly total liabilities of 56.04 Million USD for 2024 Q1, down -35.24% from previous quarter.
  • Castle Biosciences, Inc. reported quarterly total liabilities of 63.41 Million USD for 2024 Q2, up 13.16% from previous quarter.

Annual Total Liabilities Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Total Liabilities of Castle Biosciences, Inc. (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 86.54 Million USD 79.63%
2022 48.17 Million USD -5.22%
2021 50.83 Million USD 115.05%
2020 23.63 Million USD -31.75%
2019 34.63 Million USD 6.65%
2018 32.47 Million USD 34.79%
2017 24.09 Million USD 0.0%

Peer Total Liabilities Comparison of Castle Biosciences, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD -115.139%
Biodesix, Inc. 94.51 Million USD 8.437%
bioAffinity Technologies, Inc. 3.36 Million USD -2470.837%
DarioHealth Corp. 38.24 Million USD -126.283%
Exact Sciences Corporation 3.32 Billion USD 97.398%
IDEXX Laboratories, Inc. 1.77 Billion USD 95.125%
Illumina, Inc. 4.36 Billion USD 98.018%
Intelligent Bio Solutions Inc. 5.59 Million USD -1446.588%
iSpecimen Inc. 6.07 Million USD -1323.842%
Standard BioTools Inc. 159.86 Million USD 45.866%
23andMe Holding Co. 206.64 Million USD 58.121%
Medpace Holdings, Inc. 1.09 Billion USD 92.117%
NeoGenomics, Inc. 739.69 Million USD 88.3%
Inotiv, Inc. 588.04 Million USD 85.283%
Psychemedics Corporation 6.59 Million USD -1211.64%
Prenetics Global Limited 44.01 Million USD -96.627%
Precipio, Inc. 3.67 Million USD -2256.808%
RadNet, Inc. 2.07 Billion USD 95.826%
Sotera Health Company 2.68 Billion USD 96.779%
Star Equity Holdings, Inc. 21.67 Million USD -299.271%
Exagen Inc. 34.25 Million USD -152.677%
Natera, Inc. 691.79 Million USD 87.49%
Aspira Women's Health Inc. 8.62 Million USD -903.153%
Neogen Corporation 1.44 Billion USD 93.99%
Myriad Genetics, Inc. 312.9 Million USD 72.342%
ICON Public Limited Company 7.74 Billion USD 98.883%
Bionano Genomics, Inc. 118.24 Million USD 26.813%
CareDx, Inc 223.28 Million USD 61.242%
Check-Cap Ltd. 1.33 Million USD -6406.917%
Twist Bioscience Corporation 152.97 Million USD 43.426%
Guardant Health, Inc. 1.62 Billion USD 94.683%
BioNexus Gene Lab Corp. 1.74 Million USD -4868.136%
Fulgent Genetics, Inc. 139.82 Million USD 38.106%
Sera Prognostics, Inc. 25.28 Million USD -242.293%
OPKO Health, Inc. 622.47 Million USD 86.097%
Personalis, Inc. 95.65 Million USD 9.53%
Applied DNA Sciences, Inc. 8.77 Million USD -885.766%
Star Equity Holdings, Inc. 21.67 Million USD -299.271%
MDxHealth SA 121.92 Million USD 29.02%
Prenetics Global Limited 44.01 Million USD -96.627%
ENDRA Life Sciences Inc. 1.09 Million USD -7802.246%
Mainz Biomed B.V. 12.15 Million USD -611.706%
Trinity Biotech plc 83.38 Million USD -3.787%
Neuronetics, Inc. 81.64 Million USD -6.003%
bioAffinity Technologies, Inc. 3.36 Million USD -2470.837%